A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study
机构:[1]Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[2]Department of Hepatology, GuangdongProvincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China大德路总院外科大德路总院外一科广东省中医院[3]Department of Radiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China[4]NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[5]Departmentof Pathology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[6]Section of Endocrinology, Diabetes and Metabolism,Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy[7]Southampton National Institute forHealth Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK[8]Departmentof Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China[9]Institute of Hepatology, Wenzhou Medical University,Wenzhou, China[10]Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou,China
Background: Currently, there are no effective methods for assessing hepatic inflammation without resorting to histological examination of liver tissue obtained by biopsy. T2-weighted images (T2WI) are routinely obtained from liver magnetic resonance imaging (MRI) scan sequences. We aimed to establish a radiomics signature based on T2WI (T2-RS) for assessment of hepatic inflammation in people with nonalcoholic fatty liver disease (NAFLD). Methods: A total of 203 individuals with biopsy-confirmed NAFLD from two independent Chinese cohorts with liver MRI examination were enrolled in this study. The hepatic inflammatory activity score (IAS) was calculated by the unweighted sum of the histologic scores for lobular inflammation and ballooning. One thousand and thirty-two radiomics features were extracted from the localized region of interest (ROI) in the right liver lobe of T2WI and, subsequently, selected by minimum redundancy maximum relevance and least absolute shrinkage and selection operator (LASSO) methods. The T2-RS was calculated by adding the selected features weighted by their coefficients. Results: Eighteen radiomics features from Laplacian of Gaussian, wavelet, and original images were selected for establishing T2-RS. The T2-RS value differed significantly between groups with increasing grades of hepatic inflammation (P<0.01). The T2-RS yielded an area under the receiver operating characteristic (ROC) curve (AUROC) of 0.80 [95% confidence interval (CI): 0.71-0.89] for predicting hepatic inflammation in the training cohort with excellent calibration. The AUROCs of T2-RS in the internal cohort and external validation cohorts were 0.77 (0.61-0.93) and 0.75 (0.63-0.84), respectively. Conclusions: The T2-RS derived from radiomics analysis of T2WI shows promising utility for predicting hepatic inflammation in individuals with NAFLD.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82070588]; High Level Creative Talents from Department of Public Health in Zhejiang Province [S2032102600032]; Project of New Century 551 Talent Nurturing in Wenzhou; University School of Medicine of Verona, Verona, Italy; Southampton NIHR Biomedical Research Centre, UK [IS-BRC-20004]
第一作者机构:[1]Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
共同第一作者:
通讯作者:
通讯机构:[2]Department of Hepatology, GuangdongProvincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China[4]NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[9]Institute of Hepatology, Wenzhou Medical University,Wenzhou, China[10]Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou,China[*1]NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University No. 2 Fuxue Lane, Wenzhou 325000, China[*2]Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
推荐引用方式(GB/T 7714):
Zhong-Wei Chen,Huan-Ming Xiao,Xinjian Ye,et al.A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study[J].HEPATOBILIARY SURGERY AND NUTRITION.2022,11(2):212-+.doi:10.21037/hbsn-21-23.
APA:
Zhong-Wei Chen,Huan-Ming Xiao,Xinjian Ye,Kun Liu,Rafael S. Rios...&Ming-Hua Zheng.(2022).A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.HEPATOBILIARY SURGERY AND NUTRITION,11,(2)
MLA:
Zhong-Wei Chen,et al."A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study".HEPATOBILIARY SURGERY AND NUTRITION 11..2(2022):212-+